Christian Dior Group reports solid results in the first half of 2025 with revenue of €39.8 billion and profit of €9 billion despite challenging geopolitical and economic conditions ...

AdVini recorded revenue of €131.6 million in the first half of 2025, a decline of 3.7% at constant scope and exchange rates. The wine sector is facing a decline, weighing on the company's results.

Olympique Lyonnais Groupe has published its data regarding the total number of shares and voting rights as of June 30, 2025. The total number of shares stands at 175,873,471. The actual voting rights ...

On July 3, 2025, Hopium announced the schedule and specifications of its share consolidation. This purely technical transaction aims to exchange eighty shares with a par value of one euro cent for one ...

Lombard Odier Asset Management (Europe) Limited has announced a significant increase in its holdings in RM plc, reaching a 12.04% stake in the company. This change arises from an acquisition of voting ...

GENUI sells labor team to Galenica, successfully scaling business and impact. GENUI, a private investment firm, focuses on healthcare, energy transition, and digitalization ...

Worldline, a major player in payment services, has announced two engagements to assess its risk management. Accuracy and Oliver Wyman have been commissioned to audit the High Brand Risk (HBR) ...

LIBERO Football Finance AG has announced upcoming changes to its Management Board, effective July 1, 2025. The Supervisory Board has appointed Dr. Dirk Rogowski as the new Chairman. Dr. Rogowski, ...

NanoViricides, Inc. announces advancing lead candidate NV-387 into Phase II clinical development for MPox. Protocol development and site addition underway in the DRC. Focus on antiviral drug against ...

Petrofac Limited announced that the Court of Appeal has upheld an appeal against its restructuring plan. The appeal was brought by creditors linked to the Thai Oil project. This decision overturns a ...

In its Q2 FY2025 results, MedMira reported advances in product launches and clinical trials. The Halifax-based company introduced the Health Canada approved Multiplo® Rapid TP/HIV Test and the latest ...

Protagonist Therapeutics announces development candidate PN-477, a triple agonist peptide, targeting GLP-1, GIP, GCG receptors for obesity treatment. IND-enabling studies in progress, Phase I ...